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Abstract 
Patients and physicians are faced with extremely challenging choices during advanced 
cancer care.  This study addresses care for terminally ill cancer patients with a particular focus 
on communication between patients and physicians about end of life care and what steps need 
to be taken to improve outcomes for this patient population.  In addition to conducting a 
systematic review of the literature on end of life [EOL] communication between physicians and 
advanced cancer patients, as well as a review of the health quality indicators available in cancer 
care, I interviewed oncology health care providers, both internists caring for cancer patients and 
oncologists, to gain a unique perspective – that of the provider’s approach to end of life – on the 
current status of end of life communication between physicians and advanced cancer patients.  
The synthesis of data from the literature review and interviews indicates that EOL discussions 
are typically initiated too late in the disease course, at a time when patients’ quality of life is too 
low to assure that they can make treatment decisions that best align with their values and 
preferences.  Many barriers prevent physicians from engaging patients in these discussions at 
an earlier point in the disease course, but the most important barrier is physicians’ own lack of 
comfort with these discussions, complicated by patients’ and families’ discomfort, and driven by 
the fear of death and dying, and the stigma attached to them.  In order to overcome these 
barriers, physicians and patients must work toward shifting the current perception of EOL care 
and focus on creating an environment in which these topics can be broached earlier and 
directly.  
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Introduction 
Nearly a million and a half people were expected to be diagnosed with cancer in 2009.  
More than 562,000 cancer patients were expected to die in 2009, at a rate of 1,500 each day1.  
Despite the fact that over the past decade therapeutic advances in oncology care have led to 
increased survival for many patients with cancer, many cancers remain without curative 
treatment.  Along with improvements in therapeutic interventions, the palliative care field has 
also experienced an increase in resources available to improve the quality of patients’ lives 
during and after treatment.  As a result of these improvements, we now often identify a clear 
terminal phase,2 which allows for the opportunity to achieve a “good death,” defined by the 
Institute of Medicine’s Committee on Care at the End of Life as one “free from avoidable 
distress and suffering for patients, families and caregivers; in general accord with the patients’ 
families’ wishes; and reasonably consistent with clinical, cultural and ethical standards.” 3   
 Despite these opportunities, increases in the number of active treatment interventions, 
as well as an increase in spending on end of life care, continue, without a corresponding 
increase in satisfaction with care4-6.  Previous data suggest that outcomes from standard 
therapy in many advanced cancer settings are poor.  There are many aspects of advanced 
cancer care which require improvement.  One area that remains inadequately addressed is 
improving communication between physicians and patients at the end of life.  Detailed 
discussions about patients’ prognosis, care options, and end of life concerns and preferences 
are frequently delayed until very late in the course of illness.  One consequence of delayed or 
inadequate conversations about end of life care for patients with advanced cancer is a 
continued high rate of patients being treated with chemotherapy in the last weeks of life.4,7  
Some of this use reflects appropriately informed decisions, but some evidence suggests that 
when options are adequately discussed, fewer patients decide to receive chemotherapy when 
the chance of benefit is minimal.8 
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Several lines of evidence have demonstrated substantial shortcomings in the care of 
patients with terminal cancer.  When confronted with the reality that they have a terminal illness 
and that they will receive limited benefit from standard therapy, patients with advanced cancer 
are frequently forced to make a series of very difficult decisions.  The patient and physician face 
complicated choices about treatment plans, symptom management, psychosocial needs, and 
end of life care.  Although none of these problems has a simple solution, effective 
communication between the patient and his/her caretakers and the health care providers is 
likely to facilitate choices that are in line with the patient’s preferences.  Unfortunately, it has 
been well established in the literature that communication between patients and physicians is 
lacking,9-14 on all counts, from a failure to have these communications at all, to the often 
inadequate or poorly timed communication that does occur. 
 The majority of cancer care is appropriately focused on the treatment of advanced 
cancer, with the goal of preventing the progression of disease.  This focus is particularly 
prevalent in the United States, where the culture of medicine is one in which the US prides itself 
on having the preeminent and most advanced forms of treatment that can “cure” and “conquer” 
diseases.  This aggressive curative ideology has lead to the development of many 
breakthroughs in various medical fields.  However, this focus may obfuscate opportunities for 
critical discussions about prognosis, supportive options, potential trade-offs between quality of 
life and aggressive treatment approaches and the psychosocial and spiritual needs of patients.  
Difficult decisions about patients’ “end of life care” are often delayed until very late in the 
patients’ course of illness.  Consequently, patients are deprived of the opportunity to make fully 
informed decisions about their care at a time when they have a reasonable quality of life and 
can make choices that best reflect their values. 
 Limited research suggests that earlier initiation of discussions about prognosis and 
treatment can positively influence the outcomes that patients have at the end of life8 (See Figure 
1).  However, the most effective way to translate this knowledge into practice in a way that is 
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clinically meaningful is yet to be determined.  Almost all health care providers agree that there is 
no universally “correct” decision for patients facing advanced cancer.  Since each patient has 
very different values and beliefs, and each case of cancer has a unique course, physician-
patient communication in this context is critical.  This study addresses the subject of care for 
terminally ill cancer patients with a particular focus on communication between patients and 
physicians about end of life,15 and what steps need to be taken to improve outcomes for this 
patient population.   
  
 
Methods 
 In order to incorporate a variety of opinions and perspectives, this study triangulated 
several different strategies for gathering information about physician-patient communication 
about end-of-life care.  In addition to conducting a systematic review of literature on physician-
patient communication about end-of-life care, I conducted a separate literature search on quality 
of life indicators for cancer care at the end of life.  Finally, I conducted in-depth interviews with 
physicians interested in end-of-life care for cancer patients, who were able to provide 
perspectives and insights otherwise unavailable in the literature. 
 
Systematic review of literature on communication between physicians and terminally ill 
patients.   
 I searched PubMed, beginning with the following search terms: neoplasms; 
communication; physician-patient relations; and end-of-life care.  Those terms yielded 5924 
articles published in the last 5 years.  Narrowing to a final search algorithm of “neoplasms and 
communication and terminal care/psychology” resulted in 63 articles.   
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Inclusion criteria for this search were that the articles focus on either physician 
communication with terminally ill cancer patients, or their caregivers, or that they directly 
addressed the communication desires of this patient population.  Inclusion criteria also required 
that sources were not editorials.  Evidence from the systematic review, including a critical 
appraisal table, is presented in Appendix 1.  Further evaluations of the literature on quality 
indicators are presented in greater detail in Appendix 2. 
 
In-depth interviews with oncologists 
After receiving approval from the Institutional Review Board at UNC-CH, I conducted 5 
interviews with physicians who have demonstrated interest on this topic and expert informed 
opinions on end of life care for terminally ill cancer patients.  In order to recruit participants, I 
sent email messages to those whose names I had identified in the published literature, those 
who had been recommended by colleagues, or those who were identified by contacting 
academic cancer care centers.  I scheduled telephone interviews with physicians who affirmed 
their willingness to be interviewed.  At the beginning of each interview I read a standard 
explanation of the project, and asked respondents to agree to be recorded and identified.  I 
gave those who declined to be identified complete anonymity.  I interviewed 2 internists with an 
end of life care focus, 2 practicing oncologists, and a former neuro-oncologist now training to be 
a psychiatrist.   The complete interview protocol and list of respondents is presented in full in 
Appendix 4. 
I used the interviews to supplement my understanding of the literature on end of life care 
for terminally ill cancer patients, and used this data to help me develop policy recommendations 
for how to best improve communication between oncologists and patients about end of life care. 
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Results:  Physicians’ Orientations to End of Life Communication 
 In this section I synthesize the results of the literature search with insights from individual 
physician’s experiences of communication at the end of life. 
 Timing of end of life conversations.  The literature shows that the timing of end of life 
(EOL) conversations has an influence on EOL outcomes.   Earlier EOL discussion is associated 
with fewer aggressive medical interventions, earlier hospice admissions and better quality of life 
for both patients and caregivers.6,16,17  However, despite the strong association between early 
discussion and better outcomes, too few patients get such timely communication from their 
physicians.  Too often, physicians fail to communicate with patients whose cancer is advanced, 
and thereby fail to elicit their preferences for EOL care and decision making11,18,19.   
I addressed the issue of the timing of the EOL conversation with my 5 physician 
respondents.  The overwhelming theme from these interviews was that the best time to initiate 
these talks varies from patient to patient.  There is a spectrum along the course of the disease 
when it may be appropriate to initiate these conversations.  Overall, 4 of the 5 physicians 
agreed that the timing of these conversations has an effect on the outcomes at the end of life.  
The one physician who disagreed responded to the question of whether or not the timing of 
these conversations influenced patient outcome by saying, “not as much as people think it 
does.20” However, the context of this response was an emphasis of the point that if you are just 
having one conversation about EOL care, then it is probably too late in the process, so it is 
important to have these discussions early and several times, over the entire course of the 
illness, rather than thinking of one specific time to initiate the EOL conversation.   
 One physician seemed to sum up both her opinion and the prevailing group opinion this 
way:   “I think that’s one of the biggest problems in dealing with [initiating EOL discussions], is 
how it’s such a heterogeneous issue, in terms of when people are sort of emotionally ready to 
tackle that discussion.20”    
  6 
 
 
 
 
 A common theme within these interviews was the fact that these conversations need to 
take place at an earlier time, when patients have a better quality of life and are more able 
effectively and fully to participate in EOL decision making.  This assumption about the most 
helpful stage at which to initiate EOL discussion is represented in Figure 1 (p 15).  Their 
reasons for this conclusion varied, but all 5 of the physicians indicated that it was imperative for 
the patient to be able to make informed decisions that best reflected his/her value preferences, 
and that these decisions are best made when quality of life is higher, which is almost always 
earlier in the disease course. 
 In certain circumstances, patients continue to receive care with the misconception that 
the treatment may be improving their chances of survival.  One of my respondents noted this 
trend by saying, “I’ve seen a lot of patients who are getting aggressive care at the EOL who 
think that they are going to have their cancer cured and they don’t quiet understand that they 
have a non-curable disease21.”  She also stated that this lack of communication is not always 
due to the fact that the doctor failed to tell the patient, but because patients are so overwhelmed 
that they often “hear what they want to hear21.”  In her opinion, “when [patients] don’t have these 
more frank discussions, they don’t hear potentially negative things, and I don’t think that they 
prepare themselves adequately21.” 
 My interviews with these physicians illuminated the heterogeneity of the cancer disease 
process and the differing preferences of patients; my respondents’ answers made clear that the 
most important aspect of communicating with terminally ill patients is being able to engage the 
patient in order to identify his/her preferences.  If these conversations are so important, why are 
they not happening, and what is the best way to engage patients in them? 
  
 Barriers to initiating discussion.  Both the literature and my respondents described 
many different barriers to engaging patients in earlier EOL discussions.  Barriers emerging from 
the literature are presented in Table 1 (p 16); among those mentioned by physicians were the 
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difficulty of the subject matter, emotionally draining nature of the conversation, lack of time, lack 
of reimbursement, a fear that the conversation would result in loss of hope, the culture of 
medicine and the fear of failure, and physicians’ sense that they have neither the skill nor the 
comfort level they need to have EOL discussions.  In order to emphasize the gap between the 
need for effective communication and providers’ ability to do it, one of my physician respondents 
pointed out that that “¾ of the time when the patient brings up an emotional issue, the 
physicians are likely to ignore it. That’s a huge gap.  We know that they never ask patients what 
their understanding is of their illness, based on our data and based on other peoples data and 
its consistent across different countries, so yeah, huge gap.” 22 
 All 5 respondents independently argued that despite the fact that most health care 
practitioners are beginning to recognize the importance of initiating EOL discussions at an 
earlier stage, the United States medical system is farther away from being at a point where 
meaningful change can be enacted than it ought to be.  One respondent illustrated this by 
noting that in a survey she did 2 years ago, “the majority of doctors were willing to say that they 
would not talk about EOL issues with the patient with 4 months to live, until they didn’t have 
anymore chemotherapy to offer them; you know, to me, if oncologists are willing to say that in a 
survey, where there is sort of a socially desirable answer, which is, I should do it now, because 
that’s what the guidelines say, then I think that we are far from being ready.”21 
 With 4 out of the 5 physician respondents who spoke to me, I was able to ask them 
about their own personal best and worst case scenarios.  Of these 4 physicians, all of them 
were able to recall a specific worst case scenario – but only one of the 4 was able to recall a 
specific time when the conversation went well.  Physicians might be more easily able to 
remember the bad discussions due to the emotionally challenging experience that a bad EOL 
conversation can be.  One consequence of these difficult conversations is that physicians could 
be less likely to initiate these discussions with specific patients because they fear the possibility 
of it going poorly, even though it may be in the best interest of the patient (See figure 4). 
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Interventions.  Two different approaches to improving communication emerged from my 
research.  These approaches are focused on developing patient-centered tools or physician-
centered tools.  In my discussions with physicians, patient-centered tools were identified as 
standardized tools, such as questionnaires or screening assessments, which could target a 
patient’s readiness to initiate the end of life discussion.  One physician said that “taking it out of 
the doctor’s hands to standardize it more has a lot of potential.21” Standardization was 
mentioned as a potential advantage of these patient centered tools by 4 of my 5 physician 
respondents.  One of the problems with improving EOL communication is that a lack of standard 
quality measures has made quality improvement a challenge, since improvement requires 
measurement of processes and outcomes.  Standardized “readiness for conversation” tools 
would offer opportunities for commencement of improvement in performance. 
 Another advantage to using patient-centered tools is that they empower the patient and 
create a consistent means of tracking where the patient is in the process of understanding the 
meaning and consequences of his or her disease progression.  Such tools also have the 
substantial advantage of relieving physicians’ fears that they may bring EOL up with a patient 
who is not yet ready to talk about it and subsequently cause irreparable emotional damage. 
 One of my respondents considered physician-centered tools, such as communication 
training classes, role playing, and communication literature, to be a much more reasonable and 
effective form of training than to train patients to use assessment tools.  In his mind it was unfair 
to focus on patients in the setting of communicating about EOL decision-making.  He thought 
that, in order for physicians to be trained effectively, the most important aspects are 
“observation and feedback.”22  When I asked about the concern that some physicians may be 
afraid to discuss these issues because they do not want to dash patients’ hope, he responded, 
“You don’t have to be afraid. I find that I rarely scare patients and usually people are grateful, 
and part of it is not forcing anything down someone’s throat.”22 
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Discussion 
 The end of life decision making process has been, and will continue to be, a very 
important topic in both the field of medicine and the field of politics.  The confluence of 
complicated economic, cultural and emotional variables makes this area of medicine one that 
has been difficult to improve.  Despite the fact that both patients and physicians seem to agree 
that earlier and more forthright EOL conversations are desirable, there continues to be a lack of 
ability to enact meaningful systematic change17-24. 
 In the course of completing research on this topic, I realized that patient and physician 
decision making at the end of life is more a political than a medical issue.  The United States 
medical system is founded in a competitive, capitalistic culture, which results in a medical 
system which is often driven by profit, and a “treat first” mentality.  These structural impulses 
join a general American cultural proscription on death and dying as taboo subjects and, 
particularly, not something that patients or physicians are comfortable with in the context of 
treatment.  The literature and my interviews with physicians demonstrate that the greatest 
barrier to improving EOL communication between patients and physicians is the fear of death 
and dying.  Although there are other aspects that tie into the politics of EOL care, which will be 
touched on briefly, this fear is the major driver behind many of the decisions that are made at 
the end of life.   
 In order to analyze what specific variables are contributing to the fear and stigma 
surrounding EOL communication, and the subsequent hesitance to initiate these conversations, 
I used the framework propounded by political scientists M. Kent Jennings and David Sears.25,26  
In this framework, the barriers to initiating EOL discussions can be viewed as structural, 
situational, or individual (See Figure 3 and Table 1).  The variables I identified as structural are 
those related to the current fee-for-service reimbursement system.  The situational barriers are 
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those that apply to specific practices, and vary from practice to practice, depending on the 
individual practice culture.  The barriers that had to do with the internal psychological resources 
of individual patients and physicians are those that interact most heavily with the stigma 
surrounding death and dying.  These barriers ranged from the fear of ruining the patient’s hope 
for survival, to the fear of these conversations causing intense family conflict.  All of these 
barriers are important obstacles to improving EOL communication, but only the individual 
psychological barriers are analyzed in depth in this paper. 
 The continued aggressive care for terminally Ill cancer patients at the end of life is likely 
and importantly a product of the current reimbursement system (another variable contributing to 
aggression is, no doubt, the American medical culture’s general orientation toward more rather 
than less treatment).  The facts that chemotherapy is one of the most highly reimbursed 
interventions and that complicated, time-consuming EOL discussions are poorly reimbursed, 
create an incentive system for physicians in which they are rewarded for treating for as long as 
possible, as opposed to having EOL discussions.  Although this system is not likely to enter 
consciously into the decision making process of physicians, it may well influence these 
decisions on a subconscious level.  In the long term, the reimbursement system needs to be 
changed to better align incentives.  However, in the short term we need to focus on the 
variables that can more easily be altered. 
 The political and personal values that contribute to the individual psychological barriers 
preventing patients and physicians from feeling comfortable with these discussions can be 
viewed from several different angles.  According to Jennings and Niemi, comparisons of 
generations and individuals over time require examination of four phenomena: (1) continuity 
over time; and discontinuity as a function of (2) life-cycle effects, (3) generational effects, and 
(4) period effects26.  Furthermore, it is necessary to consider periodic effects of interventions or 
life events, which may shift the way an entire population views EOL decision-making.  Finally, it 
is important to identify which variables within this framework are modifiable and therefore are 
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variables that should be pursued as physicians continue to try and improve EOL 
communication. 
Recent evidence has shown that younger physicians are more comfortable initiating 
EOL conversations27,28.  This may be the result of a potential generational effect, in which 
younger physicians are receiving more effective communication training and are therefore more 
comfortable with these discussions, or it may be a product of the fact that younger physicians 
are typically more idealistic and optimistic about the usefulness of these conversations, and that 
older physicians have greater experience with the difficulties and are therefore more skeptical 
about the benefits.  If these changes are the product of a renewed dedication to communication 
training and focusing on the humanistic side of medicine, then the system changes that are 
being implemented have been effective and will be more evident with the gradual generational 
replacement of health care professionals.  However, if these reported changes are the product 
only of younger physicians publishing literature on the subject, then the system changes that 
have been instituted may not have been effective. 
 It is important that future research be directed towards establishing whether the current 
improvement in communication training for recent medical graduates is sustainable or more a 
product of recent medical graduate’s optimism for EOL communication.  It would be helpful to 
analyze published literature on EOL communication to see when the authors were trained, and 
whether or not the timing of this training had a “generational effect” on EOL outlooks.  If it were 
determined from the literature that more recent graduates, no matter the era, were likely to have 
more progressive views on EOL care and that more established clinicians were less likely to 
believe in the effectiveness of communication training, then it would highlight the fact that 
sustained, consistent change is not occurring in our medical system – rather, that in each 
generation a few providers will publish on the topic, without effecting system change – and that 
we need to continue to reevaluate how we approach training clinicians to prepare for EOL 
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communication and that this information is disseminated into practice, rather than being 
represented only in the literature. 
It is helpful to think about the level of patient and physician comfort with these 
conversations as either an “open” life cycle model or a “closed” life cycle model, as a way of 
understanding how barriers might affect patient-physician communication.  In the open life cycle 
model, the level of comfort with these discussions is subject to change based on some external 
event or intervention.  However, if the level of comfort with these discussions is viewed as 
following the closed life cycle model, then no matter what changes or resources are provided, 
patients and physicians will continue to be uncomfortable and afraid of having these 
conversations, and as they have bad experiences they will become less and less comfortable 
with these conversations and therefore have them less and less frequently (See Figure 4, p 18). 
 I would argue that those barriers that fall into the category of individual internal 
psychological barriers are barriers that can be overcome by providing patients and physicians 
with the appropriate tools and training resources to learn from these difficult encounters and 
subsequently feel more comfortable having them.  Unfortunately, it is difficult to determine what 
tools and resources are most likely to create that comfort in physicians and patients.  One of the 
main reasons for this is that there are very few validated health quality indicators for cancer 
patients at the end of life (See Appendix 2).  In the absence of valid and reliable measures, it is 
difficult to provide quantitative evidence demonstrating what type of communication training and 
resources are most. 
 However, despite this lack of validated quality indicators, research has shown that 
current communication training is effective18,28.  The challenge is instituting an infrastructure and 
a culture within the medical training community that emphasizes the importance of 
communication training.  The physicians I spoke with also highlighted the potential of focusing 
on standardized patient-centered tools that work toward validly and consistently assessing 
patients’ readiness to talk about end of life issues.  The feeling is that these tools can be 
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invaluable clinically, and that they can help to take some of the pressure off the individual 
physician, and mitigate the concern about having an inappropriately timed EOL discussion. 
 One concern about emphasizing such patient centered tools is that by focusing on the 
patient, we will reduce the emphasis we place on training physicians, that we will rely more on a 
screening tool assessing patients’ readiness, and less on training physicians who know what to 
do once the patient is ready.  This “either-or” choice does not have to be our only option.  The 
current large gap between what we know works and what most usually happens at the end of 
life, a lack of physician patient communication, can only be closed with strategies that employ 
both patient-centered and physician-centered tools. 
 Although this study produced some very interesting results, the very small sample is 
made up of only those who are willing to talk about the question -- and those who are willing to 
talk may, indeed, have genuinely different views than do those who are reluctant to talk about 
the question.  So in addition to having a small sample of convenience, of people I could reach, 
their insights may not be representative of all oncologists but, rather, of those oncologists who 
are also troubled by what they see as failures in end of life care.  To that end, these 
respondents' insights generate more hypotheses than they test.  These hypotheses revolve 
around the idea that despite the general recognition of the fact that both patients and physicians 
would benefit from a more full and open discourse regarding end of life care, both sides 
continue to avoid these discussions.  Research must be directed towards identifying how we 
can implement meaningful systematic change which will allow these conversations to happen 
on a more regular basis. 
 
Conclusion:  Barriers Can Be Dismantled 
The barriers that are preventing patients and physicians from improving communication 
about EOL issues are deeply entrenched in our political and personal views as a society.  This 
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deep entrenchment makes the prospect of improving communication very daunting and 
complicated.  However, if we are able to recognize, as a medical community and as a society, 
that these barriers exist, this is the first step in beginning to overcome them.  No single 
intervention or validated quality indicator will immediately improve EOL communication.  
Improvement in EOL communication, rather, will depend on our collective recognition of the 
current gap in care, a concerted effort to minimize the stigma associated with death and dying, 
and our willingness to embrace the fact that in some circumstances death is an inevitable 
outcome, and it is our duty to maximize the quality and comfort of this experience.  Death is 
something that we all must inevitably face.  However, it is not something we have to necessarily 
face alone.  If physicians can cultivate an end of life experience where patients are able to 
overcome the fear and stigma of death and achieve a sense of willing acceptance and peace, 
this will be more effective than any medical intervention.  As Dr. Jennifer Quinn told me, “I think 
that if we continue to view death as an individual experience, and what happens to me doesn’t 
affect the rest of society, then I don’t think the culture will ever change.”24 
.
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Figure 3: A Model for Viewing Barriers to Initiating EOL Conversations 
 
Table 1: Barriers to Improving End of Life Communication 
Structural Barriers 
Reimbursement system, lack of time, culture of medicine in the 
US 
Situational Barriers Culture of medicine at individual practice 
Individual Internal Psychological     
Barriers for Physicians and Patients 
Lack of comfort with difficult subject matter, fear of failure, lack 
of skill, lack of training, emotionally draining, fear of ruining 
hope, fear of family conflict 
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Figure 4:  Evolution of Physician Comfort with EOL Discussions Over Time: 
 Potential Differences in Physician Response to Difficult Situations 
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Appendix 1: Systematic Literature Review 
 
Methods: 
 Identification of literature.  I conducted a review of the literature addressing the 
communication between physicians and terminally ill cancer patients.  Within PubMed, the key 
search terms that were originally used were “neoplasms and communication or physician-
patient relations and end-of-life care”.  However, even when limited to the previous 5 years this 
yielded 5924 articles.  The final algorithm was “neoplasms and communication and terminal 
care/psychology”.  This search resulted in 63 articles.   
 
 Data extraction.  Of these articles identified in the literature search, inclusion criteria 
were that the articles focused on either physician communication with terminally ill cancer 
patients, or their caregivers, or that they directly addressed the communication desires of this 
patient population.  Inclusion criteria also required that sources were not simply in a narrative 
format.  
 
Results 
 Literature search.  I excluded 52 articles because they were not focused specifically on 
communication.  Of the 11 studies selected for analysis, 9 were qualitative assessments of 
communication needs of terminally ill cancer patients, 1 was a systematic review of the 
literature, and another was a narrative literature review on the topic.  Study populations ranged 
in size from 492 to 37.  Participants included adult patients with an advanced life-limiting cancer 
in any care setting, other than the Intensive Care Unit, with a life expectancy of less than 2 
years, their caregivers, and participating healthcare providers [HPs].  All of the studies were 
conducted in English, but several of the studies were conducted outside the United States.   
  19 
 
 
 
 
 
 Lack of communication from HPs.  The majority of studies found a clear lack of 
communication between HPs and the patients’ and their families.  The area most commonly 
focused upon was a lack of psychosocial support and medical communication/information10-13.  
Several articles also highlighted the fact that the diagnoses of cancer carries such an emotional 
burden with it that patients may be overwhelmed to the point that they are unable to entirely 
comprehend what is happening to them.  As a result, it is important to have supportive 
caregivers who are available and involved in the process29,30. 
 Shinjo et al. established three specific areas of communication that need to be 
addressed: effective coaching of the family on how to care for the patient; allowing the family 
enough time to grieve;  and ensuring that the family cannot overhear the conversations of the 
medical staff when they are standing outside the room10  . 
  
 Racial and ethnic variance in EOL communication.   Several cultural variations affect 
patients’ desires for EOL communication, as well as what communication physicians’ 
provide11,30,31.  Non-western countries have typically taken a more paternalistic view in 
communication of prognostic information and EOL care.  However, recent studies have shown 
that these countries are moving toward a model of more emphasis on patient/caregiver 
involvement and informed decision making. 
 Racial disparities have been observed in EOL communication and care.  For example, it 
has been shown that blacks in the United States have received less aggressive and curative 
treatment early in their disease, but that they receive more aggressive care and less palliative 
care at EOL, resulting in more ICU admissions, higher cost of care, and lower rates of 
satisfaction11.  It is important that examples like these be taken seriously and that further 
research determines whether these discrepancies are a result of true cultural differences or a 
failure of the health care system to recognize the needs of these populations. 
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 Maintaining hope while receiving prognostic information.  Balancing the need to 
provide realistic information to patients and to have upfront candid conversations about the EOL 
with the desire to maintain hope is a difficult task.  Despite the fact that physicians consistently 
overestimate the life expectancy of terminally ill cancer patients and fail to initiate conversations 
about the EOL in a timely manner, it has been shown that awareness of illness is not 
necessarily associated with increased anxiety and depression and may be related to an 
increase in spiritual well-being3233.  Maintaining and fostering hope are crucial components 
throughout the process of discussions surrounding prognosis and EOL care.  Hope is best 
engendered by a combination of empathy and honesty34. 
 
Conclusion 
 Enhanced clarity of communication about prognostic information and EOL care is an 
important and unmet need for terminally ill cancer patients.  The nature of the problem makes it 
difficult to perform quantitative research to provide clear answers as to how to best improve 
communication between HPs and cancer patients.  Nonetheless, it is essential that research 
strive to develop a framework by which these questions can be systematically reviewed and 
addressed.  
 Although psychosocial support and communication have traditionally been given less 
emphasis by the oncology community, it is becoming clear that the lack of attention to these 
problems is causing an increasing burden of suffering for the terminally ill cancer population, 
and causing the medical system to miss the opportunity to provide peaceful and satisfying EOL 
experiences for both patients and their families. 
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Table 1: Summary of Studies 
 
Study Authors/ 
Publication Date 
Study Design Study Results Study Strengths Study Weaknesses 
Trice ED, Prigerson 
HG. 
Qualitative literature 
review, focused on 
communication in the 
end of life in terminally 
ill cancer patients. 
This review found that 
terminally ill cancer patients 
suffer from distressing 
symptoms at the end of life that 
are inadequately controlled, 
that aggressive, burdensome 
care at the end of life seems to 
be becoming more common, 
and that underutilization of 
palliative care is ongoing.  It is 
likely that the oncologist-
patients relationship and 
communication affect patient 
and caregiver’s recognition of, 
and adjustment to, EOL 
prognosis and the subsequent 
shaping of EOL care that they 
receive.  
Extremely extensive 
review of the literature.  
Excellent focus on past 
literature as well as 
highlighting what can be 
done in future research to 
improve EOL care. 
There are no specified 
search criteria, nor a 
prespecified research 
question.  This allows the 
possibility of bias in 
selecting articles and 
raises the possibility that 
not all of the literature was 
reviewed. 
DeSanto-Madeya S, 
Nilsson M, Loggers 
ET, Paulk E, Stieglitz 
H, Kupersztoch YM, 
Prigerson HG. 
Qualitative multi-site 
prospective cohort 
study in which 167 
caregivers were 
interviewed. 
Level of acculturation 
contributes to differences in 
EOL preferences and decision 
making. 
One of the first studies 
to systematically look at 
the affect of cultural beliefs 
on EOL decision making. 
Low response rate in 
patients' desire for 
additional care.  
Population was recruited 
from a fairly homogenous 
area. 
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Table 1 cont 
Study Authors/ 
Publication Date 
Study Design Study Results Study Strengths Study Weaknesses 
Shinjo T, Morita T, 
Hirai K, Miyashita M, 
Sato K, Tsuneto S, 
Shima Y. 
Qualitative cross 
sectional, nationwide 
survey of bereaved 
families of cancer 
patients. 
3 components of physician-
patient/family communication 
were identified as important 
and needing improvement: 
coaching of the family on how 
to care for the patient; allowing 
family enough time to grieve; 
ensuring family cannot 
overhear conversations of 
medical staff outside the room. 
Large sample size with a 
high response rate (76%).  
Questionnaire was valid 
and addressed a broad 
range of questions, which 
allowed the research team 
to formulate a meaningful 
conclusion. 
Due to the retrospective 
nature of this study, there 
is a possibility of recall 
bias as well as selection 
bias.  Furthermore, the 
cross-sectional design 
does not allow causal 
relationships to be 
determined. 
Rainbird K, Perkins 
J, Sanson-Fisher R, 
Rolfe I, Anseline P. 
Qualitative cross-
sectional survey of 
418 eligible patients, 
of which 246 
consented to 
participate. 
Patients with advanced, 
incurable cancer have high 
levels of unmet needs, 
especially in relation to areas of 
psychological and medical 
communication/information 
needs. 
Validated questionnaire, 
the Needs Assessment for 
Advanced Cancer 
Patients, to identify unmet 
areas of need.  Clearly 
defined population and is 
likely generalizable to 
patients with all types of 
cancer. 
Performed in 
Australia/New Zealand, so 
questionable if cultural 
differences may prevent 
generalization to US. 
Mack JW, Block SD, 
Nilsson M, Wright A, 
Trice E, Friedlander R, 
Paulk E, Prigerson 
HG. 
Qualitative study in 
which The Human 
Connection (THC) 
scale was 
administered to 217 
patients with advanced 
cancer along with 
measuring emotional 
acceptance of terminal 
illness. EOL outcomes 
in 90 patients who 
died during the study 
also were examined. 
The THC measures 
therapeutic alliance between 
patients with advanced cancer 
and their physicians. In 
addition, there was no 
evidence to suggest that EOL 
discussions harm patients' 
therapeutic alliance. A strong 
therapeutic alliance was 
associated with emotional 
acceptance of a terminal illness 
and with decreased ICU care at 
the EOL among patients with 
advanced cancer. 
The first established 
validated scale to measure 
physician-patient 
relationships. Important 
step for directing further 
research for evaluating 
communication between 
physicians and terminally 
ill cancer patients. 
Only assessed at one 
point in time. Not directly 
focused on 
communication. 
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Table 1 cont     
Study Authors/ 
Publication Date 
Study Design Study Results Study Strengths Study Weaknesses 
Bachner YG, O'Rourke 
N, Davidov E, Carmel 
S 
Qualitative 
retrospective cross-
sectional study in 
which 231 family 
caregivers were 
recruited within a year 
of bereavement from 
the south and central 
health regions of 
Israel. 
Contrary to the initial 
hypothesis, retrospectively 
reported levels of mortality 
communication did not differ 
between the palliative care 
group and non-palliative care 
group.  However, lower levels 
of depressive symptomatology 
were reported by home hospice 
caregivers.  
A validated questionnaire 
was developed, along with 
an interview protocol, 
which allowed researchers 
to triangulate the research 
results and formulate clear 
hypotheses and questions 
for future research. 
Retrospective analysis 
may not fully capture how 
patients and caregivers 
actually felt at the time of 
care.  This also introduces 
the possibility of recall and 
selection bias.  The 
moderate response rate is 
comparable to other 
similar studies and reflects 
the difficulty of recruiting 
patients for this type of 
research.  Limited to a 
small geographical area in 
Israel. 
Mobeireek AF, Al-
Kassimi F, Al-Zahrani 
K, Al-Shimemeri A, al-
Damegh S, Al-Amoudi 
O, Al-Eithan S, Al-
Ghamdi B, Gamal-
Eldin M. 
Qualitative cross-
sectional study.  
Administration of a 
self-completion 
questionnaire to 321 
physicians and 264 
patients in 6 different 
regions in Saudi 
Arabia. 
There is more recognition for a 
patient's autonomy amongst 
physicians, especially in non-
western cultures.  Furthermore,  
most patients preferred a family 
centered model of car. 
One of the first surveys to 
discuss the issue of 
information disclosure in 
the Islamic community.  A 
validated questionnaire 
was used. 
Not specific to incurable 
cancer population.   
Blazeković-Milaković 
S, Matijasević I, 
Stojanović-Spehar S, 
Supe S. 
Qualitative survey of 
134 family physicians 
using a questionnaire 
focused on cancer 
care.  
When caring for terminally ill 
patients, communication is 
considered particularly difficult 
and the emotional support of 
family and friends is considered 
the most important. 
Study elicited important 
factors on desire of level of 
disclosure. 
Poorly written and the 
questionnaire used did not 
seem to be validated. 
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Appendix 2: Quality Indicators for Cancer Care at the End of Life. 
Health care institutions and professionals are under increasing pressure to provide high 
quality care that can be measured and improved.  Cancer care is one of the areas that has 
received the most attention recently, due to the devastating burden this disease places on 
patients, family, caregivers and the health care system35.  Over the past decade therapeutic 
advances in oncology care have led to increased survival for many cancers.  However, many of 
these cancers remain without a curative treatment.  Along with improvements in therapeutic 
interventions, the palliative care field has undergone many improvements that allow healthcare 
providers to improve the quality of patient’s lives during and after treatment.  Nonetheless, there 
remain few validated quality indicators to evaluate the quality of cancer care at the end of life.  
Although oncologists and palliative care specialists have dedicated significant time in recent 
years to developing validated quality measures, there remains little consensus about which 
ones should be used. 
This appendix aims to assess the current standard of care in end of life decision making 
for terminally ill cancer patients, by looking at what gaps exist in the formation of quality 
indicators for palliative cancer care.  I will begin with a look at the current health quality 
indicators for cancer care at the end of life.  Next I will look at a specific framework9 that 
attempts to address the gaps in the quality of care of terminally ill cancer patients, by presenting 
a standard method to develop and assess health quality indicators.  Finally, I will conclude with 
what research needs to be done in order to continue to improve care for cancer patients at the 
end of life.  
 .  As cancer progresses, it causes various symptoms that may lower the patient’s quality 
of life.  Pain, dyspnea, and depression, along with advance care planning are issues that have 
been shown to be important to both terminally ill cancer patients and their families.36   Based on 
a systematic review meant to identify quality indicators and their use in assessing pain, 
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dyspnea, depression and advanced care planning, I determined that although there are many 
indicators or measures for these problems, few of them have been tested specifically in a 
cancer population.  Furthermore, there is little information in the literature regarding the validity 
of these indicators and whether or not they have helped promote quality improvement9,37,38.  
 Another difficulty in palliative cancer quality measurement is that although pain 
management of patients has been identified as a problem that doctors were able to evaluate 
consistently, none of the studies that I reviewed took into consideration the possibility of 
patients’ impaired ability to competently report their own symptoms and preferences towards the 
end of life.  Cognition of cancer patients at the end of life may be affected by temporary delirium, 
or by permanent changes such as brain metastases or dementia.  Delirium has been reported in 
up to 50% of cancer patients and is likely even more prevalent in ICUs and nursing homes.39 
 Although public and scholarly concern over quality of care has increased over the last 
decade, it continues to be difficult for oncology providers to agree on consistent and valid quality 
indicators for EOL care.  One of the main reasons for this is that every patient has a notably 
different end of like experience.  Unlike other common medical conditions, in which most people 
have similar experiences, the end of life experience is unique for every patient and family.  As a 
result, it has been a challenge to establish finite quantitative indicators.  Subsequently, recent 
works have looked at patient satisfaction as a measure of success in end of life care. 
 However, the challenge has been to define satisfaction in this patient population.  Dy et 
al defined satisfaction in end of life care to include accessibility and coordination, competence in 
symptom management and comfort with dying, communication and education, emotional 
support and personalization of care, and support of patients’ decision making.40 This definition 
came from a systematic review in which only one of the studies used a satisfaction 
questionnaire which was designed for and had been psychometrically evaluated in the 
terminally ill population.  In most studies, researchers have measured satisfaction 
retrospectively from family members, which creates the possibility of introducing bias from 
  26 
 
 
 
 
perceptions about grief or anger from death or suffering and the inherent difficulties of using 
proxy reports for an experience – death – that the family member him or herself can only 
witness but cannot have firsthand. 
 The systematic review performed by Dy et al. on the satisfaction with care at the end of 
life was not specifically related to terminally ill cancer patients, but, especially given that we do 
not have consistent, established quality indicators for advanced cancer patients (despite the fact 
that the qualitative literature has identified many domains and themes), it is reasonable for us to 
extrapolate this review to the terminally ill cancer population.  The lack of agreed-upon quality 
indicators threatens to disrupt the attempt to document improved quality of palliative cancer care 
in terminally ill patients.   
 As the field of palliative care and end of life care continues to expand, it is critical that we 
work to develop validated measurements which ensure that patients are receiving the highest 
quality care possible.  As Dr. Kutner points out, “achieving this goal will require maximizing the 
use of existing validated instruments, conducting rigorous studies of interventions designed to 
improve the quality of care, and assuring that clinical organizations that care for persons at the 
end of life have the necessary training and infrastructure to participate in studies.”41  
 Recognizing the current lack of valid quality indicators, Seow et al. 42 present a 
framework that identifies five steps for developing and assessing a quality indicator for end of 
life care: define the 1 population of focus, 2 broad quality domains, 3 specific target areas, 4 
steps of the care process, and 5 evaluation criteria for quality indicators. 
 In order to define the population of focus, this framework adapts the NCP palliative care 
population definition42 to focus more specifically on terminally ill cancer patients at the end of 
life, as well as family members.  Defining the “end-of-life” population is inherently difficult, due to 
the lack of agreement about what duration of prognosis should qualify as terminally ill, as well 
as the fact that many physicians tend to overestimate the prognosis of cancer patients43.  In 
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order to ensure generalizability, this framework intentionally uses a broad end of life definition to 
address a larger range of quality issues, rather than define the population specifically.  
 In order to account for the complexity of quality of end of life care, the framework defines 
broad quality domains.  These domains were related to health related quality of life,  and 
communication and decision making,9 and were based on the domains of quality palliative care 
as defined by the NCP and NQF.44  However, since these domains were not specific to cancer 
patients, the framework added two domains, ”psychiatric” and “psychosocial”  the better to 
match the needs of cancer patients as defined by Institute of Medicine Report.45   
 Within each broad domain, the framework lists specific target areas.  This aspect of the 
model is the one which is the most difficult to validate.  It is challenging to know which specific 
target areas are most important and are most closely related to satisfaction with care.  Although 
the framework recognizes this limitation, it strives to lay out the targets that fit best with cancer 
specific indicator sets.9 
 Cancer care is a process ranging from screening to end-of-life care.  Quality measures 
must be evaluated in every step of this process.  Quality indicators may focus on steps in the 
care of process, such as the time between diagnosis and treatment, or the transitioning from 
one care team to another.  It is important to document and define the steps of the care process, 
so that it is possible to identify where quality care may be compromised. 
 Finally, quality indicators must be evaluated.  In order to do this, the framework uses the 
current NQF criteria for evaluating quality indicators: importance, scientific acceptability, 
usability and feasibility9.  These criteria can be used to ensure that the quality indicators being 
used are beneficial to the patient population. 
 Although this framework is not perfect, it is an important step towards creating an 
organized structure which will allow end-of-life care to be objectively analyzed and evaluated in 
order to improve care.  Barriers to creating valid quality indicators for end-of-life care persist, but 
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as the field of palliative care continues to grow, it is necessary that we develop the tools to 
determine if the care that we are providing to patients is effectively satisfying their needs.   
 Whether or not providers use this framework as we move forward, simply establishing a 
framework is only the first step.  Future research will need to be done in order to develop the 
most important quality indicators for various settings and populations.  It is clear that patients 
with advanced cancer sometimes do not receive adequate information, coordination of care, or 
control of pain symptoms40.  This has been established from the few indicators that are currently 
available.  However, much more work needs to be done in order to establish more relevant 
indicators and to ensure that quality indicators are an accepted part of measuring the quality of 
cancer care. 
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Appendix 3:  The In-Depth Interview 
Fact Sheet and Agreement Form: 
 
All research on human volunteers is reviewed by a committee that works to protect your rights 
and welfare.  If you have questions or concerns about your rights as a research subject, or if 
you would like to obtain information or offer input, you may contact the Institutional Review 
Board at 919-966-3113 or by email to IRB_subjects@unc.edu. 
 
End Stage Cancer Care: An Assessment of Patient-Physician End-of-Life 
Communication Preferences. 
 
Kyle Lavin 
University of North Carolina at Chapel Hill 
 
 
IRB Study #: 10-0602    
 
Consent Form Version Date:    April 1, 2010  
 
Principal Investigator:    Kyle Lavin 
UNC-Chapel Hill Department:   Public Health Leadership 
 
Faculty Advisor:     Sue Tolleson-Rinehart, PhD 
UNC-Chapel Hill Department:    Public Health Leadership & Pediatrics 
       
Advisor Phone #:      919.843.9477 
Advisor E-mail:    suetr@unc.edu 
 
Study Contact Phone #:      919-270-3660 
Study Contact E-mail:     kyle_lavin@med.unc.edu 
 
[Introductory script, embedding study information and agreement to participate:] 
 
Hello, I am Kyle Lavin.  Thank you so much for talking with me today.  I am an MD/MPH 
candidate at the University of North Carolina at Chapel Hill.  Currently, I am conducting research 
to fulfill the requirements of the Masters of Public Health degree in the Health Care & Prevention 
program at UNC.   
 
I have asked to interview you because you are an oncologist who has given thought to how best 
to communicate with your patients when they may be reaching the end of their lives as a result 
of their cancer.    
 
My advisor for this research is Dr. Sue Tolleson-Rinehart, who is a faculty member of the UNC 
Schools of Public Health and Medicine.  We hope that this project can advance understanding 
of quality of care at the end of life.  To this end, we hope that the results of this study will be 
published in a scholarly journal but our main emphasis is completing this research for my 
master’s degree. 
 
The interview will consist of several open-ended questions, and should last anywhere from 20 
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minutes to one hour, depending on the availability of your time and what you want to tell me.  
You have the right to end the interview at any time.  I would like to record this interview on a 
digital voice recorder to ensure that I have the most accurate record of your comments.  
However, I will not record this interview without your permission.   
 
If you do grant permission for this conversation to be recorded, you have the right to revoke 
recording permission at any time.  The digital interview files created will be kept password-
protected on my computer and the computer of my faculty advisor, Dr. Tolleson-Rinehart, until I 
transcribe the interview.  After the transcript is made, the files will be deleted.  This transcript will 
also be kept password-protected on our computers, and only Dr. Tolleson-Rinehart and I will 
know this password.  I will be happy to provide you with a copy of the interview’s transcript at 
your request. 
 
I will not identify your comments by name in my written work unless you grant me permission to 
do so today.  If you do not grant this permission, I will identify you by position only – for 
example, “An oncologist at an Eastern academic medical center.”   
 
If you have any questions about the research now, please ask.  If you have questions later 
about the research, please contact me by phone at 919-270-3660 or by e-mail at 
kyle_lavin@med.unc.edu or kyle.lavin@gmail.com      
 
Dr. Tolleson-Rinehart and I hope to publish the results of this project, and will be glad to make 
findings available to you.  If you wish to ask Dr. Tolleson-Rinehart any questions about the 
study, please send a message to suetr@unc.edu or call 919.843.9477. 
 
Before we continue, would you please agree to any or all of the statements I’m about to read?   
 
   I AGREE to having this interview tape recorded with a digital voice recorder.   
 
   I  GIVE PERMISSION for the following information to be included in publications 
resulting from this study: 
 
  my name     my title        direct quotes from this interview  
 
 
 
 
                                                                         .                                                   . 
 
Name of Participant     Date 
 
 
Thank you for your help with my project!  Now we are ready to begin. 
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Interview Protocol 
 
 
1. As you know, the health care system has been increasingly concerned with quality of 
care during potentially terminal illnesses.  The literature shows that both oncologists and 
patients are not always comfortable starting the end of life conversation.  Can you tell me what 
you think about having these conversations? 
 
[Follow-ups and probes if needed] That is, I’d like your views on when the conversation should 
start, and under what circumstances.   
 
 
 
 
2. Ideally, what do you think are the best ways to have these conversations? 
 
 
 
3.   And similarly, hypothetically, what do you think are the biggest barriers to having them? 
 
 
 
4. And now I’d like to ask about your own experience.  Can you give me examples of the 
best and worst end of life conversations you yourself have been a part of? 
 
 
 
5.   Do you think the timing of such conversations influences the patient’s end of life 
experience? 
 
 
6. Who initiates these conversations?  That is, I understand that patients can be very 
different, but in general, how do you see this process unfolding? 
 
 
7. Do you think oncologists have the resources they need to handle end of life 
conversations appropriately?  That is, I’d like to ask you whether you think some things would 
be more or less helpful: 
 
a. Would it help to have some scripts, or other training resources, to help 
oncologists prepare for these conversations? 
 
 
b. Would it be useful to have a resource for patients, like a questionnaire or study 
guide or something else to help them to think these questions through before having the 
conversation with their oncologist? 
 
 
c. What reimbursement changes do you think might contribute to oncologists being 
able to deliver better end of life care? 
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Thank you very much for your time!  I greatly appreciate it!  Is there anything I haven’t thought of 
that you’d like to add? 
 
 
I will be happy to provide you with a copy of this interview’s transcript, if you would like.  Thank 
you again!  
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Appendix 4: List of Interviewees 
MD, MPH, Hematologist Oncologist.  University of Virginia, Charlottesville Va.  An expert in 
chemotherapy, multidisciplinary treatment of gastrointestinal cancers, and the use of 
chemotherapy in the elderly.  
 
Carrie Lee, MD, MPH.  Associate Medical Director of Medical and Scientific Services, Quintiles 
Transnational Corporation, and Adjunct Clinical Assistant Professor of Oncology, UNC Chapel 
Hill. 
 
Nancy L. Keating, MD, MPH, is an associate professor of medicine and of health care policy at 
Harvard Medical School and an associate physician at Brigham and Women’s Hospital.  Dr. 
Keating’s research focuses on the quality of care delivered to patients with cancer and the 
influence of physicians, hospitals, and health care systems on care delivery.  Other work has 
assessed communication between patients and physicians and among physicians.  
 
MD, Internal Medicine,  Experience in Palliative care and extensive publications on physician-
patient communication during terminal illness. 
 
Jennifer Quinn, MD.   A former Assistant Professor at the Brain Tumor Center at Duke 
University, currently a resident physician in psychiatry at the University of Chapel hill, NC.  Dr. 
Quinn has extensive experience caring for terminally ill cancer patients.  
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